시장보고서

상품코드

1587503

D-다이머 검사 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 방법별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

D-dimer Testing Market Size, Share & Trends Analysis Report By Product, By Test Type (Clinical Laboratory, POC), By Method (ELISA, LETIA, FIA), By Application (DVT, PE, DIC), By End Use, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2024년 10월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

D-다이머 검사 시장 성장 및 동향:

세계 D-다이머 검사 시장 규모는 2030년 24억 6,000만 달러에 달할 것으로 예상되며, 2025년부터 2030년까지 CAGR 4.5%로 성장할 것으로 예상됩니다.

D다이머 검사의 기술 발전은 의료 전문가가 환자에게 적절한 응급 지원을 제공할 수 있는 다양한 제품 개발로 이어졌으며, D다이머 검사의 자동화 개념은 신속하고 노동 집약적이지 않으며 사용자 친화적인 진단 전략을 제공하여 가까운 장래에 시장을 주도할 것으로 예상됩니다.

D-다이머 항체는 피브린 분해 산물(FDP)도 검출하기 때문에 시중에서 판매되는 측정법은 항체의 특이성에 차이가 있어 잘못된 결과를 초래하는 경우가 많습니다. 이 문제를 해결하기 위해 어드밴스드 이뮤노케미컬은 FDP와 D-다이머 모두에 특이적인 원스텝 면역분석법을 설계하여 두 종류의 단클론항체를 개발했습니다. 이처럼 모든 FDP를 균등하게 검출하는 개선된 면역분석법의 개발은 시장 성장을 촉진할 것으로 예상됩니다.

특정 집단에 대한 새로운 D 다이머의 역치를 결정하기 위한 광범위한 연구는 컴퓨터 단층 촬영 폐동맥 조영술(CTPA)의 사용을 방지합니다. 이는 CTPA가 필요하지 않아 방사선 노출이 줄어들어 검사 수요가 증가하기 때문에 유익합니다. 이를 입증하기 위해 일본 연구진은 일본인의 폐색전증 진단을 위한 새로운 D-다이머 상승 기준치를 결정했습니다. 이러한 연구는 시장 성장을 촉진할 것으로 예상됩니다.

D-다이머 검사 시장 보고서 하이라이트

시약 및 소모품이 2024년 가장 큰 매출 점유율을 차지했는데, 이는 시약의 광범위한 가용성과 빈번한 사용으로 인한 것입니다.
면역분석의 효율성을 높이기 위해 이종 항체의 간섭을 줄이는 차단제의 존재가 시약 및 소모품 부문을 견인할 것입니다.
시간 단축, 사용 편의성, 최고 수준의 품질 결과 생성은 현장 검사(Point-of-Care Testing)의 성장에 도움이 되는 몇 가지 요소 중 하나입니다.
효소 결합 면역 흡착 분석법(ELISA)이 가장 큰 매출 점유율을 차지하는 이유는 마이크로플레이트 ELISA가 응고 마커에 대한 민감도가 높기 때문에 기준법으로 간주되기 때문입니다.
심부정맥혈전증(DVT)은 이 검사가 신뢰할 수 있는 방법이고 DVT의 일상적인 선별 검사로 사용되기 때문에 2024년 매출 점유율을 독차지했습니다.
2024년 병원 부문이 가장 큰 매출 비중을 차지했습니다.
이는 입원 환자 중 폐색전증 환자의 비율이 증가함에 따라 병원 내 검사 도입률이 높아졌기 때문입니다.
아시아태평양은 다양한 질병에서 이러한 분석법 사용과 관련된 연구 조사를 지원하는 자금 지원 이니셔티브가 증가함에 따라 유리한 CAGR을 보일 것으로 예상됩니다.
중국 국가자연과학기금(National Natural Science Foundation of China)과 중앙대학 기초연구기금(Fundamental Research Funds for the Central Universities) 등은 중국 내 조사 연구에 자금을 지원하는 몇 안 되는 기관 중 하나입니다. 자금을 제공하는 몇 안 되는 기관 중 하나입니다.
시장에서 사업을 운영하는 주요 기업들은 제품 포트폴리오를 확장하기 위해 몇 가지 성장 이니셔티브를 시행하고 있습니다.
예를 들어, 2019년 2월 호리바는 DVT 및 폐색전증 측정 및 기준 제외 테스트를 위한 Yumizen D 다이머 시약 키트를 발표했습니다.

지역별 시장 점유율 분석, 2024년 및 2030년
지역 시장 대시보드
시장 규모, 예측 동향 분석, 2018년에서 2030년 :
북미
- 국가별, 2018-2030년
- 미국
- 캐나다
- 멕시코
유럽
- 국가별, 2018-2030년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 국가별, 2018-2030년
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 국가별, 2018-2030년
- 브라질
- 아르헨티나
중동 및 아프리카
- 국가별, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제10장 경쟁 상황

참여자 개요
기업의 시장 포지션 분석
기업 분류
전략 매핑
기업 개요/상장 기업
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Siemens Healthcare
- Abbott
- BIOMERIEUX
- WERFEN
- HORIBA, Ltd.
- QuidelOrtho Corporation
- Diazyme Laboratories
- Biomedica Diagnostics
- SEKISUI Diagnostics

ksm 24.11.21

D-dimer Testing Market Growth & Trends:

The global D-dimer testing market size is expected to reach USD 2.46 billion in 2030 and is projected to grow at a CAGR of 4.5% from 2025 to 2030. Technological advancements in D-dimer testing have resulted in the development of a wide range of products that have allowed healthcare professionals to offer suitable emergency assistance to patients. The concept of automation in D-dimer testing has provided rapid, less labor-intensive, and user-friendly diagnostic strategies, which is expected to drive the market in the near future.

The commercially available assays often have differences in their antibody specificity as D-dimer antibodies also detect Fibrin Degradation Products (FDPs), leading to incorrect results. To address this issue, Advanced ImmunoChemical, Inc. has developed two monoclonal antibodies, which are used to design one-step immunoassay specific for both FDP and D-dimer. Thus, the development of improved immunoassays that equally detect all FDPs is expected to boost the market growth.

Extensive research for the determination of new D-dimer threshold values for a specific population set prevents the usage of Computed Tomography Pulmonary Angiography (CTPA). This is beneficial as the elimination of CTPA leads to low radiation exposure, which, in turn, increases the demand for the test. To demonstrate this, a group of researchers from Japan determined new elevated D-dimer threshold values for the diagnosis of pulmonary embolism in the Japanese population. Such studies are expected to favor market growth.

D-dimer Testing Market Report Highlights:

Reagents and consumables accounted for the largest revenue share in 2024 owing to the wide availability and frequent usage of reagents in the market space
Presence of blocking agents that reduce the interferences from heterophilic antibodies to increase the efficiency of immunoassays boost the reagents and consumables segment
Shorter turnaround times, ease of use, and generation of gold-standard quality results are among the few factors that lead to a lucrative growth of point-of-care testing
Enzyme-linked Immunosorbent Assays (ELISA) held the largest revenue share because microplate ELISA is considered as a reference method due to its high sensitivity for coagulation markers
Deep Vein Thrombosis (DVT) dominated the revenue share in 2024 as this test is a reliable method and is used as a routine screening test for DVT
The hospitals' segment accounted for the maximum revenue share in 2024
This is attributive to a rise in the rate of pulmonary embolism cases in hospitalized patients, which results in high adoption of the test in hospitals
Asia Pacific is expected to witness a lucrative CAGR due to a rise in the funding initiatives that support research studies related to the usage of these assays in various diseases
The National Natural Science Foundation of China and the Fundamental Research Funds for the Central Universities are among the few agencies involved in funding research studies in China
Key companies operating in the market have undertaken several growth initiatives to expand their product portfolio
For instance, in February 2019, HORIBA introduced the Yumizen D-Dimer reagent kit for measurement and reference exclusion testing for DVT and pulmonary embolism.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Test Type
- 1.2.3. Method
- 1.2.4. Application
- 1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. D-dimer Testing Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. D-dimer Testing Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Analyzers
- 4.4.1. Analyzers Market, 2018 - 2030 (USD Million)
4.5. Reagents & Consumables
- 4.5.1. Reagents & Consumables Market, 2018 - 2030 (USD Million)

Chapter 5. D-dimer Testing Market: Test Type Business Analysis

5.1. Test Type Market Share, 2024 & 2030
5.2. Test Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
5.4. Clinical Laboratory Tests
- 5.4.1. Clinical Laboratory Tests Market, 2018 - 2030 (USD Million)
5.5. Point-of-Care Tests
- 5.5.1. Point-of-Care Tests Market, 2018 - 2030 (USD Million)

Chapter 6. D-dimer Testing Market: Method Business Analysis

6.1. Method Market Share, 2024 & 2030
6.2. Method Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Method, 2018 to 2030 (USD Million)
6.4. Enzyme-linked Immunosorbent Assay (ELISA)
- 6.4.1. Enzyme-linked Immunosorbent Assay (ELISA) Market, 2018 - 2030 (USD Million)
6.5. Latex-enhanced Immunoturbidimetric Assays
- 6.5.1. Latex-enhanced Immunoturbidimetric Assays Market, 2018 - 2030 (USD Million)
6.6. Fluorescence Immunoassays
- 6.6.1. Fluorescence Immunoassays Market, 2018 - 2030 (USD Million)
6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. D-dimer Testing Market: Application Business Analysis

7.1. Application Market Share, 2024 & 2030
7.2. Application Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Deep Vein Thrombosis (DVT)
- 7.4.1. Deep Vein Thrombosis (DVT) Market, 2018 - 2030 (USD Million)
7.5. Pulmonary Embolism (PE)
- 7.5.1. Pulmonary Embolism (PE) Market, 2018 - 2030 (USD Million)
7.6. Disseminated Intravascular Coagulation (DIC)
- 7.6.1. Disseminated Intravascular Coagulation (DIC) Market, 2018 - 2030 (USD Million)
7.7. Others
- 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. D-dimer Testing Market: End Use Business Analysis

8.1. End Use Market Share, 2024 & 2030
8.2. End Use Segment Dashboard
8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Hospitals
- 8.4.1. Hospitals Market, 2018 - 2030 (USD Million)
8.5. Academic & Research Institutes
- 8.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
8.6. Diagnostic Centers
- 8.6.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
8.7. Others
- 8.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. D-dimer Testing Market: Regional Estimates & Trend Analysis by Product, Test Type, Method, Application, and End Use

9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.4. North America
- 9.4.1. North America D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Regulatory Framework
  - 9.4.2.3. Competitive Insights
  - 9.4.2.4. U.S. D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Regulatory Framework
  - 9.4.3.3. Competitive Insights
  - 9.4.3.4. Canada D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Regulatory Framework
  - 9.4.4.3. Competitive Insights
  - 9.4.4.4. Mexico D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.5. Europe
- 9.5.1. Europe D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.5.2. UK
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Regulatory Framework
  - 9.5.2.3. Competitive Insights
  - 9.5.2.4. UK D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Regulatory Framework
  - 9.5.3.3. Competitive Insights
  - 9.5.3.4. Germany D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. France
  - 9.5.4.1. Key Country Dynamics
  - 9.5.4.2. Regulatory Framework
  - 9.5.4.3. Competitive Insights
  - 9.5.4.4. France D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Italy
  - 9.5.5.1. Key Country Dynamics
  - 9.5.5.2. Regulatory Framework
  - 9.5.5.3. Competitive Insights
  - 9.5.5.4. Italy D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Spain
  - 9.5.6.1. Key Country Dynamics
  - 9.5.6.2. Regulatory Framework
  - 9.5.6.3. Competitive Insights
  - 9.5.6.4. Spain D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Norway
  - 9.5.7.1. Key Country Dynamics
  - 9.5.7.2. Regulatory Framework
  - 9.5.7.3. Competitive Insights
  - 9.5.7.4. Norway D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Denmark
  - 9.5.8.1. Key Country Dynamics
  - 9.5.8.2. Regulatory Framework
  - 9.5.8.3. Competitive Insights
  - 9.5.8.4. Denmark D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Sweden
  - 9.5.9.1. Key Country Dynamics
  - 9.5.9.2. Regulatory Framework
  - 9.5.9.3. Competitive Insights
  - 9.5.9.4. Sweden D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.6. Asia Pacific
- 9.6.1. Asia Pacific D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.6.2. Japan
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Regulatory Framework
  - 9.6.2.3. Competitive Insights
  - 9.6.2.4. Japan D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Regulatory Framework
  - 9.6.3.3. Competitive Insights
  - 9.6.3.4. China D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Regulatory Framework
  - 9.6.4.3. Competitive Insights
  - 9.6.4.4. India D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. South Korea
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Regulatory Framework
  - 9.6.5.3. Competitive Insights
  - 9.6.5.4. South Korea D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. Australia
  - 9.6.6.1. Key Country Dynamics
  - 9.6.6.2. Regulatory Framework
  - 9.6.6.3. Competitive Insights
  - 9.6.6.4. Australia D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
  - 9.6.7.1. Key Country Dynamics
  - 9.6.7.2. Regulatory Framework
  - 9.6.7.3. Competitive Insights
  - 9.6.7.4. Thailand D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.7. Latin America
- 9.7.1. Latin America D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
  - 9.7.2.1. Key Country Dynamics
  - 9.7.2.2. Regulatory Framework
  - 9.7.2.3. Competitive Insights
  - 9.7.2.4. Brazil D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Argentina
  - 9.7.3.1. Key Country Dynamics
  - 9.7.3.2. Regulatory Framework
  - 9.7.3.3. Competitive Insights
  - 9.7.3.4. Argentina D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
9.8. MEA
- 9.8.1. MEA D-dimer Testing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
  - 9.8.2.1. Key Country Dynamics
  - 9.8.2.2. Regulatory Framework
  - 9.8.2.3. Competitive Insights
  - 9.8.2.4. South Africa D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
  - 9.8.3.1. Key Country Dynamics
  - 9.8.3.2. Regulatory Framework
  - 9.8.3.3. Competitive Insights
  - 9.8.3.4. Saudi Arabia D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
  - 9.8.4.1. Key Country Dynamics
  - 9.8.4.2. Regulatory Framework
  - 9.8.4.3. Competitive Insights
  - 9.8.4.4. UAE D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
  - 9.8.5.1. Key Country Dynamics
  - 9.8.5.2. Regulatory Framework
  - 9.8.5.3. Competitive Insights
  - 9.8.5.4. Kuwait D-dimer Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Participant Overview
10.2. Company Market Position Analysis
10.3. Company Categorization
10.4. Strategy Mapping
10.5. Company Profiles/Listing
- 10.5.1. Thermo Fisher Scientific Inc.
  - 10.5.1.1. Overview
  - 10.5.1.2. Financial Performance
  - 10.5.1.3. Product Benchmarking
  - 10.5.1.4. Strategic Initiatives
- 10.5.2. F. Hoffmann-La Roche Ltd
  - 10.5.2.1. Overview
  - 10.5.2.2. Financial Performance
  - 10.5.2.3. Product Benchmarking
  - 10.5.2.4. Strategic Initiatives
- 10.5.3. Siemens Healthcare
  - 10.5.3.1. Overview
  - 10.5.3.2. Financial Performance
  - 10.5.3.3. Product Benchmarking
  - 10.5.3.4. Strategic Initiatives
- 10.5.4. Abbott
  - 10.5.4.1. Overview
  - 10.5.4.2. Financial Performance
  - 10.5.4.3. Product Benchmarking
  - 10.5.4.4. Strategic Initiatives
- 10.5.5. BIOMERIEUX
  - 10.5.5.1. Overview
  - 10.5.5.2. Financial Performance
  - 10.5.5.3. Product Benchmarking
  - 10.5.5.4. Strategic Initiatives
- 10.5.6. WERFEN
  - 10.5.6.1. Overview
  - 10.5.6.2. Financial Performance
  - 10.5.6.3. Product Benchmarking
  - 10.5.6.4. Strategic Initiatives
- 10.5.7. HORIBA, Ltd.
  - 10.5.7.1. Overview
  - 10.5.7.2. Financial Performance
  - 10.5.7.3. Product Benchmarking
  - 10.5.7.4. Strategic Initiatives
- 10.5.8. QuidelOrtho Corporation
  - 10.5.8.1. Overview
  - 10.5.8.2. Financial Performance
  - 10.5.8.3. Product Benchmarking
  - 10.5.8.4. Strategic Initiatives
- 10.5.9. Diazyme Laboratories
  - 10.5.9.1. Overview
  - 10.5.9.2. Financial Performance
  - 10.5.9.3. Product Benchmarking
  - 10.5.9.4. Strategic Initiatives
- 10.5.10. Biomedica Diagnostics
  - 10.5.10.1. Overview
  - 10.5.10.2. Financial Performance
  - 10.5.10.3. Product Benchmarking
  - 10.5.10.4. Strategic Initiatives
- 10.5.11. SEKISUI Diagnostics
  - 10.5.11.1. Overview
  - 10.5.11.2. Financial Performance
  - 10.5.11.3. Product Benchmarking
  - 10.5.11.4. Strategic Initiatives

D-다이머 검사 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 방법별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

D-dimer Testing Market Size, Share & Trends Analysis Report By Product, By Test Type (Clinical Laboratory, POC), By Method (ELISA, LETIA, FIA), By Application (DVT, PE, DIC), By End Use, By Region, And Segment Forecasts, 2025 - 2030

D-다이머 검사 시장 성장 및 동향:

D-다이머 검사 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 D-다이머 검사 시장 변수, 동향, 범위

제4장 D-다이머 검사 시장 : 제품별 비즈니스 분석

제5장 D-다이머 검사 시장 : 검사 유형별 비즈니스 분석

제6장 D-다이머 검사 시장 : 방법별 비즈니스 분석

제7장 D-다이머 검사 시장 : 용도별 비즈니스 분석

제8장 D-다이머 검사 시장 : 최종 용도별 비즈니스 분석

제9장 D-다이머 검사 시장 : 제품, 검사 유형, 방법, 용도, 최종 용도별 지역 추정·동향 분석